Zobrazeno 1 - 8
of 8
pro vyhledávání: '"BERSZIN, MICHAEL"'
Autor:
Berszin, Michael, Michaelides, Ioannis, Siemert, Julia, Röhl, Louisa, Wellhausen, Jana, Wald, Theresa, Bohr, Christopher, Künzel, Julian, Gradistanac, Tanja, Dietz, Andreas, Zebralla, Veit, Pirlich, Markus, Wiegand, Susanne, Wichmann, Gunnar
Background: Pembrolizumab and cetuximab are antibodies under investigation in head and neck squamous cell carcinoma (HNSCC) either as single agents or combined with cisplatin and other chemotherapeutic drugs, e.g., 5-fluorouracil and/or docetaxel. Ho
Externí odkaz:
https://ul.qucosa.de/id/qucosa%3A84568
https://ul.qucosa.de/api/qucosa%3A84568/attachment/ATT-0/
https://ul.qucosa.de/api/qucosa%3A84568/attachment/ATT-0/
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
GÖBEL, VOLKMAR, BÜNEMANN, JENS, BERSZIN, MICHAEL, THÜNE, OLIVIA-SOPHIA, PEDERZANI, NILS, SCHWARZER, MARCUS
Publikováno v:
Quintessenz der Zahntechnik; Mar2024, Vol. 50 Issue 3, p282-294, 13p
Autor:
Röhl, Louisa, Wellhausen, Jana, Berszin, Michael, Krücken, Irene, Zebralla, Veit, Pirlich, Markus, Wiegand, Susanne, Dietz, Andreas, Wald, Theresa, Wichmann, Gunnar
Publikováno v:
Frontiers in Immunology; 2023, p1-15, 15p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Michaelides, Ioannis, Fest, Sandra, Berszin, Michael, Wiegand, Susanne, Bohr, Christopher, Künzel, Julian, Dietz, Andreas, Pirlich, Markus, Wichmann, Gunnar
Publikováno v:
Onkologische Welt; April 2023, Vol. 14 Issue: 2 p90-95, 6p
Autor:
Michaelides, Ioannis, Fest, Sandra, Berszin, Michael, Wiegand, Susanne, Bohr, Christopher, Künzel, Julian, Dietz, Andreas, Pirlich, Markus, Wichmann, Gunnar
Publikováno v:
Tumordiagnostik & Therapie; Dec2022, Vol. 43 Issue 10, p680-684, 5p
Autor:
Berszin M; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Leipzig, Leipzig, Germany., Michaelides I; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Leipzig, Leipzig, Germany.; Department of Otorhinolaryngology, University Hospital Regensburg, Regensburg, Germany., Siemert J; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Leipzig, Leipzig, Germany., Röhl L; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Leipzig, Leipzig, Germany., Wellhausen J; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Leipzig, Leipzig, Germany., Wald T; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Leipzig, Leipzig, Germany., Bohr C; Department of Otorhinolaryngology, University Hospital Regensburg, Regensburg, Germany., Künzel J; Department of Otorhinolaryngology, University Hospital Regensburg, Regensburg, Germany., Gradistanac T; Department of Pathology, University Hospital Leipzig, Leipzig, Germany., Dietz A; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Leipzig, Leipzig, Germany., Zebralla V; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Leipzig, Leipzig, Germany., Pirlich M; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Leipzig, Leipzig, Germany., Wiegand S; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Leipzig, Leipzig, Germany., Wichmann G; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Leipzig, Leipzig, Germany.
Publikováno v:
Frontiers in oncology [Front Oncol] 2022 Feb 28; Vol. 12, pp. 795277. Date of Electronic Publication: 2022 Feb 28 (Print Publication: 2022).